Lv1
40 积分 2021-06-02 加入
Antibody engineering
11小时前
待确认
Boosting Natural Killer Cells’ Immunotherapy with Amoxicillin-Loaded Liposomes
1个月前
已完结
Structural and functional insights into CD3 bispecific antibodies targeting DLL3 in cancer immunotherapy
2个月前
已完结
The complex patent situation regarding antibody Fc engineering
2个月前
已完结
Surface Charge and Solvent Exposure Dictate the pH-Dependent Viscosity of Therapeutic Antibodies
4个月前
已完结
Nanobody-based bispecific antibody engagers targeting CTLA-4 or PD-L1 for cancer immunotherapy
8个月前
已完结
Discovery and development of bispecific antibodies
8个月前
已完结
New insights into antibody structure with implications for specificity, variable region restriction and isotype choice
8个月前
已完结
Trends and Challenges in Bispecific Antibody Production
8个月前
已完结
The rise of China’s pharmaceutical industry from 2015–2024: a decade of innovation
10个月前
已完结
皖公网安备34019202002308
